Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Assess the clinical safety and long term effects of recombinant human growth hormone on a
defined range of nutritional indices in malnourished chronic hemodialysis and continuous
ambulatory peritoneal dialysis patients.
Phase:
N/A
Details
Lead Sponsor:
FDA Office of Orphan Products Development
Collaborators:
Vanderbilt University Vanderbilt University Medical Center